Stiege W, Erdmann V A
Institut für Biochemie, Freie Universität Berlin, Germany.
J Biotechnol. 1995 Jul 31;41(2-3):81-90. doi: 10.1016/0168-1656(95)00005-b.
Recent developments indicate that with the in vitro protein biosynthesis system a new technology emerges, which will find in the future its application in biotechnology. Up to date the best system described produces 2 mg of proteins per 0.5 ml after 100 h. The potentials of the in vitro protein biosynthesis system include not only the production of proteins, but especially the synthesis of proteins, which are toxic to living cells, or proteins with unnaturally modified or isotope-labelled amino acids in specific positions. Among the advantages of the in vitro system, when compared to current cloning techniques, are the purity of the proteins synthesized and their superior biological activities. Thus, the application of this technology will be manifold ranging from the production of proteins with improved or even new characteristics to the potentials of improving the methods of protein design and structural characterization.
最近的进展表明,随着体外蛋白质生物合成系统的出现,一项新技术应运而生,该技术未来将在生物技术领域得到应用。迄今为止,所描述的最佳系统在100小时后每0.5毫升可产生2毫克蛋白质。体外蛋白质生物合成系统的潜力不仅在于蛋白质的生产,更在于合成对活细胞有毒的蛋白质,或在特定位置具有非天然修饰或同位素标记氨基酸的蛋白质。与当前的克隆技术相比,体外系统的优势在于合成蛋白质的纯度及其卓越的生物学活性。因此,这项技术的应用将是多方面的,从生产具有改进甚至新特性的蛋白质到改善蛋白质设计和结构表征方法的潜力。